|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1007290591 |
| 003 |
OCoLC |
| 005 |
20231120010226.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
171024s2017 maua ob 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d IDEBK
|d YDX
|d OPELS
|d EBLCP
|d UPM
|d OCLCF
|d OHS
|d OCLCO
|d D6H
|d MEU
|d VT2
|d OCLCA
|d OCLCQ
|d DKU
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1007577005
|a 1029874790
|a 1055394925
|a 1081232222
|a 1125688339
|a 1132152166
|a 1136443500
|a 1162112323
|a 1228649923
|a 1235834352
|a 1244637125
|a 1261769421
|a 1262688739
|
| 020 |
|
|
|a 9780128124741
|q (electronic bk.)
|
| 020 |
|
|
|a 0128124741
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128124734
|
| 020 |
|
|
|z 0128124733
|
| 035 |
|
|
|a (OCoLC)1007290591
|z (OCoLC)1007577005
|z (OCoLC)1029874790
|z (OCoLC)1055394925
|z (OCoLC)1081232222
|z (OCoLC)1125688339
|z (OCoLC)1132152166
|z (OCoLC)1136443500
|z (OCoLC)1162112323
|z (OCoLC)1228649923
|z (OCoLC)1235834352
|z (OCoLC)1244637125
|z (OCoLC)1261769421
|z (OCoLC)1262688739
|
| 050 |
|
4 |
|a QP552.N39
|
| 072 |
|
7 |
|a NAT
|x 019000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI
|x 070030
|2 bisacsh
|
| 082 |
0 |
4 |
|a 599.0188
|2 23
|
| 100 |
1 |
|
|a Thiele, Todd E.
|q (Todd Eric),
|d 1967-
|e author.
|
| 245 |
1 |
4 |
|a The role of neuropeptides in addiction and disorders of excessive consumption /
|c Todd E. Thiele.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press,
|c [2017]
|
| 264 |
|
4 |
|c �2017
|
| 300 |
|
|
|a 1 online resource :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a International review of neurobiology ;
|v v. 136
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 588 |
0 |
|
|a Vendor-supplied metadata.
|
| 505 |
0 |
|
|a Front Cover -- The Role of Neuropeptides in Addiction and Disorders of Excessive Consumption -- Copyright -- Contents -- Contributors -- Preface -- Chapter One: Neuropeptides and Addiction: An Introduction -- References -- Chapter Two: Corticotropin-Releasing Factor (CRF) and Addictive Behaviors -- 1. Introduction -- 2. CRF Stress Systems -- 3. CRF, the HPA Axis, and Addiction -- 4. Extrahypothalamic CRF Systems -- 5. Role for CRF-CRF1 Systems in Animal Models of Addiction -- 6. Central Extended Amygdala -- 6.1. Cellular Mechanisms of CRF
|
| 505 |
8 |
|
|a 7. Ventral Tegmental Area8. Prefrontal Cortex -- 9. Compulsive Eating -- 10. Conclusion -- Acknowledgments -- References -- Chapter Three: Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction -- 1. Introduction -- 1.1. Stress, Addiction, and Kappa Opioid Receptors -- 1.2. Modulation of Neurotransmitter Signaling by Kappa Opioid Receptors -- 1.3. Kappa Opioid Receptors in the NAc -- 1.4. Kappa Opioid Receptors in the VTA -- 1.5. Measuring Dynorphin Levels -- 1.6. Opponent Process Theory of Addiction
|
| 505 |
8 |
|
|a 1.7. Sex Differences in Kappa Opioid Receptor Function2. Ethanol and Kappa Opioid Receptors -- 2.1. Kappa Opioid Receptors and Ethanol Consumption -- 2.2. Kappa Opioid Receptors and Chronic Ethanol Exposure -- 2.3. Ethanol Effects on the Dynorphin/Kappa Opioid Receptor System -- 2.4. Ethanol, Kappa Opioid Receptors, and Dopamine -- 3. Cocaine and Kappa Opioid Receptors -- 3.1. Chronic Stress, Kappa Opioid Receptors, and Cocaine -- 3.2. Timing of Kappa Opioid Receptor Activation, Dopamine Deficits, and Cocaine Effects -- 3.3. Kappa Opioid Receptors and DATs
|
| 505 |
8 |
|
|a 3.4. Cocaine, Kappa Opioid Receptors, and DATs3.5. Reinstatement of Cocaine Self-Administration -- 4. Obesity and Kappa Opioid Receptors -- 4.1. The Dynorphin/Kappa Opioid Receptor System and Hereditary Obesity -- 4.2. Dynorphin/Kappa Opioid Receptor System and Palatable Food Consumption -- 4.3. Dynorphin/Kappa Opioid Receptor System and Food Deprivation -- 5. Kappa Opioid Receptor-Based Therapeutics -- References -- Further Reading -- Chapter Four: The Role of the Ghrelin System in Drug Addiction -- 1. Introduction -- 2. Ghrelin and Alcohol
|
| 505 |
8 |
|
|a 2.1. Preclinical Evidence2.2. Clinical Evidence -- 3. Ghrelin and Stimulants -- 3.1. Preclinical Evidence -- 3.2. Clinical Evidence -- 4. Ghrelin and Tobacco/Nicotine -- 4.1. Preclinical Evidence -- 4.2. Clinical Evidence -- 5. Ghrelin and Opioids -- 5.1. Preclinical Evidence -- 6. Ghrelin and Cannabis -- 6.1. Preclinical Evidence -- 6.2. Clinical Evidence -- 7. Conclusions -- Acknowledgments and Disclosures -- References -- Chapter Five: The Role of the Melanocortin System in Drug and Alcohol Abuse -- 1. Introduction -- 2. Melanocortin Receptors
|
| 546 |
|
|
|a Text in English.
|
| 650 |
|
0 |
|a Neuropeptides.
|
| 650 |
|
0 |
|a Compulsive behavior.
|
| 650 |
|
2 |
|a Neuropeptides
|0 (DNLM)D009479
|
| 650 |
|
2 |
|a Compulsive Behavior
|0 (DNLM)D003192
|
| 650 |
|
6 |
|a Neuropeptides.
|0 (CaQQLa)201-0023738
|
| 650 |
|
6 |
|a Comportement compulsif.
|0 (CaQQLa)201-0075080
|
| 650 |
|
7 |
|a addiction.
|2 aat
|0 (CStmoGRI)aat300189146
|
| 650 |
|
7 |
|a NATURE
|x Animals
|x Mammals.
|2 bisacsh
|
| 650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Zoology
|x Mammals.
|2 bisacsh
|
| 650 |
|
7 |
|a Compulsive behavior
|2 fast
|0 (OCoLC)fst00871935
|
| 650 |
|
7 |
|a Neuropeptides
|2 fast
|0 (OCoLC)fst01036450
|
| 776 |
0 |
8 |
|i Print version:
|a Thiele, Todd E. (Todd Eric), 1967-
|t Role of neuropeptides in addiction and disorders of excessive consumption.
|b First edition.
|d Cambridge, MA : Academic Press, [2017]
|z 9780128124734
|z 0128124733
|w (OCoLC)985078855
|
| 830 |
|
0 |
|a International review of neurobiology ;
|v v. 136.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/00747742/136
|z Texto completo
|
